These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35372049)

  • 41. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.
    Li C; Zou H; Xiong Z; Xiong Y; Miyagishima DF; Wanggou S; Li X
    Front Genet; 2020; 11():429. PubMed ID: 32508873
    [No Abstract]   [Full Text] [Related]  

  • 42. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
    Ye Y; Dai Q; Qi H
    Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
    Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
    Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer.
    Zhang F; Zhong W; Li H; Huang K; Yu M; Liu Y
    Front Cell Dev Biol; 2021; 9():665265. PubMed ID: 34124046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
    Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
    Front Genet; 2021; 12():696912. PubMed ID: 34512722
    [No Abstract]   [Full Text] [Related]  

  • 47. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 50. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
    Li J; Li X; Zhang C; Zhang C; Wang H
    Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma.
    Hwangbo S; Kim SI; Kim JH; Eoh KJ; Lee C; Kim YT; Suh DS; Park T; Song YS
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
    Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
    Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
    [No Abstract]   [Full Text] [Related]  

  • 53. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
    Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
    Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
    [No Abstract]   [Full Text] [Related]  

  • 55. Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response.
    Zhang H; Wu Y; Li H; Sun L; Meng X
    Cancer Cell Int; 2021 Nov; 21(1):593. PubMed ID: 34736480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Six-mRNA risk score system and nomogram constructed for patients with ovarian cancer.
    Wang Q; Lu Z; Ma J; Zhang Q; Wang N; Qian L; Zhang J; Chen C; Lu B
    Oncol Lett; 2019 Aug; 18(2):1235-1245. PubMed ID: 31423184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
    Chen L; Tian B; Liu W; Liang H; You Y; Liu W
    Front Oncol; 2022; 12():855674. PubMed ID: 35425715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
    Zhang F; Feng D; Wang X; Gu Y; Shen Z; Yang Y; Wang J; Zhong Q; Li D; Hu H; Han P
    Front Mol Biosci; 2021; 8():780329. PubMed ID: 35004850
    [No Abstract]   [Full Text] [Related]  

  • 59. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.